Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Azelaic Acid vs Tazarotene: Azelaic Acid has the stronger overall evidence (7.5 vs 7.5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Azelaic Acid wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
0 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both Azelaic Acid and Tazarotene have evidence — compare verdict strength side-by-side.
Topical only. OTC cosmetic azelaic acid is typically around 10%; prescription strengths are 15% gel/foam (rosacea) and 20% cream (acne), applied as a thin layer to clean skin once or twice daily. There is no oral, injectable, or systemic dose. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route. This library does not provide an ingestion protocol.
Any time of day
Leave-on topical gel, foam, or cream (OTC ~10%, or prescription 15-20%)
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Tazarotene 0.045% lotion
Throughout
4-15 weeks
8-24 weeks
4-12 weeks
immediate
12 weeks
24 weeks
1-4 weeks
Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.
J Am Acad Dermatol (2003) · RCT · n=664
Two double-blind, vehicle-controlled phase III RCTs (664 patients total) of 15% azelaic acid gel twice daily for moderate papulopustular rosacea
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Arch Dermatol (2003) · RCT · n=251
Multicenter, double-blind, randomized head-to-head trial in 251 patients with moderate papulopustular rosacea over 15 weeks
Interventions for rosacea.
Cochrane Database Syst Rev (2015) · Systematic Review
Cochrane review of 106 RCTs (13,631 participants) of rosacea treatments with GRADE quality assessment
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
J Drugs Dermatol (2020) · RCT · n=1614
The two identical phase 3 registration trials for the 0.045% lotion — 1614 subjects aged 9 and older.
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
J Drugs Dermatol (2020) · RCT · n=684
A pooled paediatric SUBGROUP analysis of the two phase 3 trials, not a separate trial: 136 patients aged 10-13 and 548 aged 14-17.
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial
Arch Dermatol (2002) · RCT · n=563
The long photodamage trial: 24 weeks double-blind, then a 28-week open-label extension — 12 months in total, 563 patients.
Azelaic Acid has a higher evidence score (7.5/10 vs 7.5/10) and wins in 2 of 3 categories.
For clearer skin (acne), Tazarotene has a higher relevance score (88 vs 70).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
AM/PM order, what to combine vs separate, and why sunscreen always comes first.
The proven core (sunscreen, retinoids, vitamin C) vs the viral hype tier — honestly tiered.
The depigmenter playbook (hydroquinone, azelaic, tranexamic, vitamin C) with sunscreen as the spine.
Benzoyl peroxide & retinoids → salicylic/azelaic/niacinamide → naturals, tiered by evidence.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.